Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Royal DSM NV (DSM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7164
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop residues and bio-chemicals. The company serves customers in animal nutrition and health, packaging and graphic arts, building and construction, pharma solutions, electrical and electronics, automotive, medical, personal care, energy, food, furniture, life protection, beverages and dietary supplements, marine, paint and coatings, manufacturing and equipment, sports, leisure and consumer goods, and textiles and clothing sectors. The company has operations across Eastern Europe, Latin America, North America, Asia, and other regions. DSM is headquartered in Heerlen, the Netherlands.

Royal DSM NV (DSM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Royal DSM NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Royal DSM NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Royal DSM NV, Medical Equipment, Deal Details 10
Venture Financing 10
MIACH Orthopaedics Raises USD22.5 Million in Series A Venture Financing 10
Bio2 Technologies Raises USD4.5 Million in Series C Financing 11
Essential Medical Raises USD15 Million in Series B Financing 12
Interface Biologics Raises Funds Through Extended Series B Venture Financing 13
Regentis Biomaterials Raises US$10 Million In Series C Financing 14
Partnerships 15
DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 15
Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 16
Vention Medical Enters into Agreement with Royal DSM 17
Royal DSM Enters into Distribution Agreement with Sebbin 18
DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 19
Debt Offering 20
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 20
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 21
Acquisition 22
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 22
Royal DSM NV – Key Competitors 24
Royal DSM NV – Key Employees 25
Royal DSM NV – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 29
Recent Developments 31
Strategy And Business Planning 31
Apr 03, 2017: Royal DSM Opens New Biotechnology Center in Delft, the Netherlands 31
Financial Announcements 32
Aug 01, 2018: DSM announces H1 2018 results 32
May 08, 2018: DSM Reports Q1 2018 Results 33
Feb 15, 2018: DSM Reports 2017 Results 34
May 02, 2017: DSM Q1 2017 Results 41
Feb 15, 2017: DSM reports 2016 results 42
Feb 14, 2017: DSM new presentation of accounts as from Q4 2016 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Royal DSM NV, Medical Equipment, Key Facts, 2017 2
Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Royal DSM NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Royal DSM NV, Deals By Market, 2012 to YTD 2018 8
Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MIACH Orthopaedics Raises USD22.5 Million in Series A Venture Financing 10
Bio2 Technologies Raises USD4.5 Million in Series C Financing 11
Essential Medical Raises USD15 Million in Series B Financing 12
Interface Biologics Raises Funds Through Extended Series B Venture Financing 13
Regentis Biomaterials Raises US$10 Million In Series C Financing 14
DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 15
Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 16
Vention Medical Enters into Agreement with Royal DSM 17
Royal DSM Enters into Distribution Agreement with Sebbin 18
DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 19
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 20
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 21
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 22
Royal DSM NV, Key Competitors 24
Royal DSM NV, Key Employees 25
Royal DSM NV, Other Locations 26
Royal DSM NV, Subsidiaries 26
Royal DSM NV, Joint Venture 29

List of Figures
Royal DSM NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Royal DSM NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Royal DSM NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medicago Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. I …
  • Selvita SA (SLV):企業の財務・戦略的SWOT分析
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • China Shineway Pharmaceutical Group Ltd (2877):企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • Crescita Therapeutics Inc (CTX)-製薬・医療分野:企業M&A・提携分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company’s product portfolio includes over-the-counter and prescription products such as topical creams. It offers pliaglis, a local anesthetic cream for superficial …
  • Knights of Columbus:企業の戦略的SWOT分析
    Knights of Columbus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • InterOil Exploration & Production ASA (IOX):石油・ガス:M&Aディール及び事業提携情報
    Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, develops and operates oil and natural gas properties, among others. It operates as an active license partner in se …
  • Innergex Renewable Energy Inc:企業の発電所・SWOT分析2018
    Innergex Renewable Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Alps Industries Ltd.:企業の戦略・SWOT・財務分析
    Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JAND, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary JAND, Inc. (JIN), doing business a warby parker, is a manufacturing company. The company engages in operations of optical manufacturer. JIN product portfolio consists of eyeglasses, sunglasses, and gift cards. The company also manufactures and sale of eyewear for men and women. It also offer …
  • Strukton Groep NV:企業の戦略・SWOT・財務情報
    Strukton Groep NV - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Belk Inc:企業の戦略・SWOT・財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Daelim Industrial Co Ltd:戦略・SWOT・企業財務分析
    Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hewlett Packard Enterprise Company:企業の戦略・SWOT・財務情報
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Societe Generale Private Banking:企業の戦略・SWOT・財務分析
    Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report Summary Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Fubon Bank (Hong Kong) Limited:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Obalon Therapeutics Inc (OBLN):医療機器:M&Aディール及び事業提携情報
    Summary Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gast …
  • Reece Ltd (REH):企業の財務・戦略的SWOT分析
    Reece Ltd (REH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • SkylineDx BV:企業の製品パイプライン分析
    Summary SkylineDx BV (SkylineDx) is a developer and commercializer of gene signature-based diagnostic tests for personalized medicine in oncology. The company offers MMprofiler and AMLprofiler molecular diagnostic tests for blood cancers. Its AMLprofiler is a vitro diagnostic test that recognizes ac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆